Nexalin (NXL) Revenue & Revenue Breakdown
Nexalin Revenue Highlights
Latest Revenue (Y)
$168.72K
Latest Revenue (Q)
$36.03K
Main Segment (Y)
Licensing Fee
Main Geography (Y)
CHINA
Nexalin Revenue by Period
Nexalin Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $168.72K | 52.35% |
| 2023-12-31 | $110.75K | -91.62% |
| 2022-12-31 | $1.32M | 817.20% |
| 2021-12-31 | $144.06K | -40.69% |
| 2020-12-31 | $242.91K | 17.13% |
| 2019-12-31 | $207.38K | - |
Nexalin generated $168.72K in revenue during NA 2024, up 52.35% compared to the previous quarter, and up 81.36% compared to the same period a year ago.
Nexalin Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $36.03K | 34.24% |
| 2024-06-30 | $26.84K | -65.88% |
| 2024-03-31 | $78.67K | 283.09% |
| 2023-12-31 | $20.54K | -14.83% |
| 2023-09-30 | $24.11K | -32.15% |
| 2023-06-30 | $35.54K | 16.30% |
| 2023-03-31 | $30.56K | -20.47% |
| 2022-12-31 | $38.42K | -92.95% |
| 2022-09-30 | $545.32K | 31.63% |
| 2022-06-30 | $414.29K | 28.13% |
| 2022-03-31 | $323.32K | 1247.23% |
| 2021-12-31 | $24.00K | -57.12% |
| 2021-09-30 | $55.97K | 91.99% |
| 2021-06-30 | $29.15K | -16.57% |
| 2021-03-31 | $34.94K | 7.51% |
| 2020-12-31 | $32.50K | -11.93% |
| 2020-09-30 | $36.91K | -57.46% |
| 2020-06-30 | $86.75K | -0.00% |
| 2020-03-31 | $86.75K | - |
Nexalin generated $36.03K in revenue during Q3 2024, up 34.24% compared to the previous quarter, and up 101.38% compared to the same period a year ago.
Nexalin Revenue Breakdown
Nexalin Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|
| Device Sales | $55.50K | $1.16M | - |
| Equipment | $37.83K | $27.30K | $26.78K |
| Licensing Fee | $69.50K | $82.08K | $79.19K |
| Other | $5.89K | $1.37K | $26.41K |
Nexalin's latest annual revenue breakdown by segment (product or service), as of Dec 24: Licensing Fee (41.19%), Device Sales (32.89%), Equipment (22.42%), and Other (3.49%).
Quarterly Revenue by Product
| Product/Service | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 |
|---|---|---|---|---|---|---|---|---|---|
| Equipment | $17.51K | $18.80K | $1.51K | $10.62K | $5.18K | $5.10K | $6.40K | $4.75K | $4.10K |
| Other | $5.51K | $288.00 | $100.00 | $2.00 | $270.00 | $807.00 | $290.00 | $275.00 | $110.00 |
| Device Sales | - | $55.50K | $9.60K | - | $520.00K | - | - | - | - |
| Licensing Fee | $31.00K | $16.94K | $21.56K | $19.51K | $18.66K | $20.03K | $23.87K | $18.63K | $21.11K |
Nexalin's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Licensing Fee (57.39%), Equipment (32.42%), and Other (10.19%).
Nexalin Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|
| CHINA | $85.25K | $3.61K | $1.21M |
| UNITED STATES | $83.47K | $107.13K | $113.54K |
Nexalin's latest annual revenue breakdown by geography, as of Dec 24: CHINA (50.53%), and UNITED STATES (49.47%).
Quarterly Revenue by Country
| Country | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 |
|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $39.64K | $20.66K | $23.17K | $27.13K | $24.11K | $25.33K | $30.56K | $23.68K | $25.32K |
| CHINA | - | - | - | - | $10.21K | $14.75K | $520.00K | - | - |
Nexalin's latest quarterly revenue breakdown by geography, as of Dec 24: UNITED STATES (100.00%).
Nexalin Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LIVN | LivaNova | $1.25B | $318.11M |
| KIDS | OrthoPediatrics | $204.73M | $52.80M |
| SRDX | Surmodics | $126.08M | $29.92M |
| NPCE | NeuroPace | $79.91M | $21.06M |
| LNSR | LENSAR | $53.49M | $13.54M |
| IRIX | IRIDEX | $48.67M | $11.58M |
| SSKN | STRATA Skin Sciences | $33.56M | $8.44M |
| NXL | Nexalin | $168.72K | $36.03K |
| AIMD | Ainos | - | - |
| BJDX | Bluejay Diagnostics | - | - |
| MODD | Modular Medical | - | - |